Multiplex Assays Market by Type {Nucleic Acid-Based Multiplex Assays (Planar Nucleic Acid Assays and Bead-Based Nucleic Acid Assays), Protein-Based Multiplex Assays (Planar Protein Assays and Bead-Based Protein Assays), and Other Multiplex Assays}, Product {Multiplex Assay Reagents & Consumables, Multiplex Assay Accessories & Instruments, and Multiplex Assay Software & Services}, Technology {Multiplex PCR, Multiplex Protein Microarray, and Other Technologies}, Application {Companion Diagnostics, Research & Development (Drug Development and Biomarker Discovery & Validation), Clinical Diagnostics (Cancer, Infectious Diseases, Cardiac Diseases, Autoimmune Diseases, Alzheimer’s Disease, and Other Diseases)}, and End User {Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies} - Global Opportunity Analysis and Industry Forecast, 2014-2022
- ALL1152056
- 180 Pages
- April 2017
- Medical Devices
A multiplex assay is a procedure in which multiple analytes (proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. These assays are used to amplify multiple targets in a polymerase chain reaction (PCR) experiment and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional method, such as ELISA. Multiplex assays are used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. The global multiplex assays market has accounted for $3,470 million in 2015, and is estimated to reach $5,720 million by 2022, growing at a CAGR of 7.4% during the analysis period 2016-2022.
The multiplex assays market has witnessed growth owing to increase in R&D activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimer’s. Multiplex assays are used in clinical trials as they decrease the cost of research and manual labor, and increase the efficiency of experiment and therapies. In addition, multiplex assays are easier, faster, and automated as compared to conventional methods, thus fuels the market growth. However, high capital investment and dearth of skilled labor hamper the market growth.
The global multiplex assays market in this report is studied based on type, product, technology, application, end user, and geography. On the basis of type, it is divided into nucleic acid-based, protein-based multiplex assays, and other multiplex assays; nucleic acid-based and protein-based multiplex assays segment is further bifurcated into planar and bead-based assays. Based on product, it is classified into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services.
Based on technology, it is classified into multiplex PCR, multiplex protein microarray, and other technologies. Based on application, it is categorized into companion diagnostics, research & development, and clinical diagnostics. R&D segment is further bifurcated into drug development and biomarker discovery & validation. Clinical diagnostics segment is further subsegmented into cancer, infectious diseases, cardiac diseases, autoimmune diseases, Alzheimer’s disease, and others. On the basis of end user, it is divided into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
Key Benefits
- The study provides an in-depth analysis of the global multiplex assays market, with current trends and future estimations to elucidate the investment pockets.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- The report provides a quantitative analysis that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of different segments (product, type, technology, application, and end user) facilitates in understanding the various type of products and technology used for different applications.
- Key players are profiled in this report and their strategies are analyzed thoroughly, which predicts the competitive outlook of market.
Key Market Segment
By Type
- Nucleic Acid-Based Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-Based Nucleic Acid Assays
- Protein-Based Multiplex Assays
- Planar Protein Assays
- Bead-Based Protein Assays
- Other Multiplex Assays
By Product
- Multiplex Assay Reagents & Consumables
- Multiplex Assay Instruments & Accessories
- Multiplex Assay Software &Services
By Technology
- Multiplex PCR
- Multiplex Protein Microarray
- Other Technologies
By Application
- Companion Diagnostics
- R&D
- Drug Development
- Biomarker Discovery and Validation
- Clinical Diagnostics
- Cancer
- Infectious Diseases
- Cardiac Diseases
- Autoimmune Diseases
- Alzheimer’s Disease
- Other Diseases
By End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceuticals & Biotechnological Companies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, 2015
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 MULTIPLEX ASSAYS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market Size and Forecast
4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
4.2.1. Key Market Trends
4.2.2. Key Growth Factors and Opportunities
4.2.3. Market Size and Forecast
4.2.4. Planar Nucleic Acid Multiplex Assays
4.2.5. Bead-Based Nucleic Acid Multiplex Assays
4.3. PROTEIN-BASED MULTIPLEX ASSAYS
4.3.1. Key Market Trends
4.3.2. Key Growth Factors And Opportunities
4.3.3. Market Size and Forecast
4.3.4. Planar Protein Multiplex Assays
4.3.5. Bead-Based Protein Multiplex Assays
4.4. OTHER MULTIPLEX ASSAYS
4.4.1. Key Market Trends
4.4.2. Key Growth Factors And Opportunities
4.4.3. Market Size And Forecast
CHAPTER 5 MULTIPLEX ASSAYS MARKET, BY PRODUCT
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. MULTIPLEX ASSAYS REAGENTS & CONSUMABLES
5.2.1. Market size and forecast
5.3. MULTIPLEX ASSAYS INSTRUMENTS AND ACCESSORIES
5.3.1. Market size and forecast
5.4. MULTIPLEX ASSAY SOFTWARE AND SERVICES
5.4.1. Market size and forecast
CHAPTER 6 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. MULTIPLEX PCR
6.2.1. Market size and forecast
6.3. MULTIPLEX PROTEIN MICROARRAY
6.3.1. Market size and forecast
6.4. OTHER TECHNOLOGIES
6.4.1. Market size and forecast
CHAPTER 7 MULTIPLEX ASSAYS MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. COMPANION DIAGNOSTICS
7.2.1. Market size and forecast
7.3. RESEARCH & DEVELOPMENT
7.3.1. Market size and forecast
7.3.2. Drug Development: Market Size and Forecast
7.3.3. Biomarker Discovery and Validation: Market Size and Forecast
7.4. CLINICAL DIAGNOSTICS
7.4.1. Market size and forecast
7.4.2. Cancer: Market Size and Forecast
7.4.3. Infectious Diseases: Market Size and Forecast
7.4.4. Cardiac Diseases: Market Size and Forecast
7.4.5. Autoimmune Diseases: Market Size and Forecast
7.4.6. Alzheimers Disease: Market Size and Forecast
7.4.7. Other Diseases: Market Size and Forecast
CHAPTER 8 MULTIPLEX ASSAYS MARKET, BY END USER
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. HOSPITALS
8.2.1. Market size and forecast
8.3. CLINICAL LABORATORIES
8.3.1. Market size and forecast
8.4. RESEARCH INSTITUTES
8.4.1. Market size and forecast
8.5. PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES
8.5.1. Market size and forecast
CHAPTER 9 MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. NORTH AMERICA
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.4. U.S. market size and forecast
9.2.5. Canada market size and forecast
9.2.6. Mexico market size and forecast
9.3. EUROPE
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.4. Germany market size and forecast
9.3.5. France market size and forecast
9.3.6. UK market size and forecast
9.3.7. Italy market size and forecast
9.3.8. Spain market size and forecast
9.3.9. Rest of Europe market size and forecast
9.4. ASIA-PACIFIC
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities.
9.4.3. Market size and forecast
9.4.4. Japan market size and forecast
9.4.5. China market size and forecast
9.4.6. India market size and forecast
9.4.7. Rest of Asia-Pacific market size and forecast
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.4. Latin America market size and forecast
9.5.5. Middle East market size and forecast
9.5.6. Africa market size and forecast
CHAPTER 10 COMPANY PROFILES
10.1. LUMINEX CORPORATION
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.1.6. Key strategic moves and developments
10.2. THERMO FISHER SCIENTIFIC, INC.
10.2.1. Company overview
20.2.2. Company snapshot
20.2.3. Operating business segments
20.2.4. Product portfolio
20.2.5. Business performance
20.2.6. Key strategic moves and developments
10.3. ILLUMINA, INC.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.3.6. Key strategic moves and developments
10.4. BIO-RAD LABORATORIES, INC.
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business performance
10.4.6. Key strategic moves and developments
10.5. QIAGEN N.V.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance
10.5.6. Key strategic moves and developments
10.6. BECTON, DICKINSON AND COMPANY
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Business performance
10.6.6. Key strategic moves and developments
10.7. ABCAM PLC
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments
10.8. SEEGENE INC.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments
10.9. MESO SCALE DIAGNOSTICS, LLC
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments
10.10. RANDOX LABORATORIES LTD.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 2. GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 4. GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5. GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 8. GLOBAL MULTIPLEX ASSAY REAGENTS & CONSUMABLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 9. GLOBAL MULTIPLEX ASSAY INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. GLOBAL MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET FOR MULTIPLEX PCR, BY REGION, 2014-2022 ($MILLION)
TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET FOR PROTEIN MICROARRAY, BY REGION, 2014-2022 ($MILLION)
TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2014-2022 ($MILLION)
TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2014-2022 ($MILLION)
TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2014-2022 ($MILLION)
TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2014-2022 ($MILLION)
TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2014-2022 ($MILLION)
TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2014-2022 ($MILLION)
TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET FOR HOSPITALS, BY REGION, 2014-2022 ($MILLION)
TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2014-2022 ($MILLION)
TABLE 24. GLOBAL MULTIPLEX ASSAYS FOR RESEARCH INSTITUTES, BY REGION, 2014-2022 ($MILLION)
TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES, BY REGION, 2014-2022 ($MILLION)
TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET, BY REGION, ($MILLION), 2014-2022
TABLE 27. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 28. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 2014-2022
TABLE 29. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 30. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 31. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 32. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, ($MILLION), 2014-2022
TABLE 33. EUROPE: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 34. EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 2014-2022
TABLE 35. EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 36. EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 37. EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 38. EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 39. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 40. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 20142022
TABLE 41. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 42. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 43. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 44. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, ($MILLION), 2014-2022
TABLE 45. LAMEA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 46. LAMEA: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 20142022
TABLE 47. LAMEA: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 48. LAMEA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 49. LAMEA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 50. LAMEA: MULTIPLEX ASSAYS MARKET, BY END USER, ($MILLION), 2014-2022
LIST OF FIGURES
FIGURE 1. MULTIPLEX ASSAYS: MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS, 2015
FIGURE 6. PLANAR NUCLEIC ACID MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 7. BEAD-BASED NUCLEIC ACID MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 8. PLANAR PROTEIN MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 9. BEAD-BASED PROTEIN MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET FOR DRUG DEVELOPMENT, 2014-2022 ($MILLION)
FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY AND VALIDATION, 2014-2022 ($MILLION)
FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF CANCER, 2014-2022 ($MILLION)
FIGURE 13. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF INFECTIOUS DISEASES, 2014-2022 ($MILLION)
FIGURE 14. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF CARDIAC DISEASES, 2014-2022 ($MILLION)
FIGURE 15. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF AUTOIMMUNE DISEASES, 2014-2022 ($MILLION)
FIGURE 16. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF ALZHEIMERS DISEASE, 2014-2022 ($MILLION)
FIGURE 17. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DISGNOSTICS OF OTHER DISEASES, 2014-2022 ($MILLION)
FIGURE 18. U.S. HEALTHCARE EXPENDITURE BY GDP (%)
FIGURE 19. U.S.: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 20. CANADA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 21. MEXICO: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 22. EUROPE HEALTHCARE EXPENDITURE BY GDP (%)
FIGURE 23. GERMANY: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 24. FRANCE: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 25. UK: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 26. ITALY: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 27. SPAIN: MULTIPLEX ASSAYS MARKET, ($MILLION), 20142022
FIGURE 28. REST OF EUROPE: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 29. GDP OF ASIAN COUNTRIES ($TRILLION), 2016
FIGURE 30. JAPAN: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 31. CHINA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 32. INDIA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 33. REST OF ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 34. LATIN AMERICA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 35. MIDDLE EAST: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 36. AFRICA: MULTIPLEX ASSAYS MARKET ($MILLION), 2014-2022
FIGURE 37. LUMINEX CORPORATION: COMPANY SNAPSHOT
FIGURE 38. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 39. ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 40. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 41. QIAGEN N.V.: COMPANY SNAPSHOT
FIGURE 42. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 43. ABCAM PLC, SEEGENE INC.: COMPANY SNAPSHOT
FIGURE 44. MESO SCALE DIAGNOSTICS, LLC: COMPANY SNAPSHOT
FIGURE 45. RANDOX LABORATORIES LTD.: COMPANY SNAPSHOT
FIGURE 46. SEEGENE INC.: COMPANY SNAPSHOT
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
